CA2715100C - Nouveau recepteur trem (recepteur activateur exprime dans les cellules myeloides) et ses utilisations - Google Patents

Nouveau recepteur trem (recepteur activateur exprime dans les cellules myeloides) et ses utilisations Download PDF

Info

Publication number
CA2715100C
CA2715100C CA2715100A CA2715100A CA2715100C CA 2715100 C CA2715100 C CA 2715100C CA 2715100 A CA2715100 A CA 2715100A CA 2715100 A CA2715100 A CA 2715100A CA 2715100 C CA2715100 C CA 2715100C
Authority
CA
Canada
Prior art keywords
trem
polypeptide
cells
expression
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA2715100A
Other languages
English (en)
Other versions
CA2715100A1 (fr
Inventor
Marco Colonna
Axel Bouchon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cosmo Technologies Ltd
Original Assignee
Cosmo SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cosmo SpA filed Critical Cosmo SpA
Priority claimed from CA2342376A external-priority patent/CA2342376C/fr
Publication of CA2715100A1 publication Critical patent/CA2715100A1/fr
Application granted granted Critical
Publication of CA2715100C publication Critical patent/CA2715100C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2715100A 2001-03-20 2001-03-28 Nouveau recepteur trem (recepteur activateur exprime dans les cellules myeloides) et ses utilisations Expired - Lifetime CA2715100C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27723801P 2001-03-20 2001-03-20
US60/277,238 2001-03-20
CA2342376A CA2342376C (fr) 2001-03-20 2001-03-28 Nouveau recepteur trem (recepteur activateur exprime dans les cellules myeloides) et ses utilisations

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA2342376A Division CA2342376C (fr) 2001-03-20 2001-03-28 Nouveau recepteur trem (recepteur activateur exprime dans les cellules myeloides) et ses utilisations

Publications (2)

Publication Number Publication Date
CA2715100A1 CA2715100A1 (fr) 2002-09-20
CA2715100C true CA2715100C (fr) 2015-10-06

Family

ID=43064694

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2715100A Expired - Lifetime CA2715100C (fr) 2001-03-20 2001-03-28 Nouveau recepteur trem (recepteur activateur exprime dans les cellules myeloides) et ses utilisations

Country Status (1)

Country Link
CA (1) CA2715100C (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113332417A (zh) * 2021-04-27 2021-09-03 大汉生物科技(广东)有限公司 Trem-2在制备肿瘤治疗药物和/或诊断试剂中的应用

Also Published As

Publication number Publication date
CA2715100A1 (fr) 2002-09-20

Similar Documents

Publication Publication Date Title
CA2342376C (fr) Nouveau recepteur trem (recepteur activateur exprime dans les cellules myeloides) et ses utilisations
US8231878B2 (en) Receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
US20170320946A1 (en) Receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
US11414490B2 (en) Regulatory T cell mediator proteins and uses thereof
US20090081199A1 (en) Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
JP6175170B2 (ja) Ｖｉｓｔａ制御性ｔ細胞メディエータタンパク質、ｖｉｓｔａ結合剤、およびその使用
US7976840B2 (en) Use of anti-GL50 antibodies for the downmodulation of an immune response
US20230015969A1 (en) Regulatory t cell mediator proteins and uses thereof
US20060263770A1 (en) Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
US20060246065A1 (en) Fail molecules and uses thereof
CA2715100C (fr) Nouveau recepteur trem (recepteur activateur exprime dans les cellules myeloides) et ses utilisations
EP1223218A1 (fr) Molecules CD2000 et CD2001 et utilisations de celles-ci
EP1900816A2 (fr) Molécules de gl50 et leurs utilisations

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20210329